# Dorzolamide + Timolol

## Cosopt 2/0.5% 5ml ophthalmic solution

| TAH Drug Code      | [ECOS](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ECOS)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension, open-angle glaucoma, pseudoexfoliative glaucoma or other secondary open-angle glaucomas when concomitant therapy is appropriate.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Dosing             | Instill 1 drop BID into the conjunctival sac. Limited data available with child under 2 years old. Shake well before using.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Contraindications  | Bronchial asthma or a history of bronchial asthma, or severe COPD, sinus bradycardia, 2nd or 3rd degree AV block, overt cardiac failure, cardiogenic shock.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Adverse Effects    | Taste perversion, ocular burning &/or stinging, conjunctival hyperemia, blurred vision, superficial punctate keratitis or eye itching. Cardiovascular: Angina, Bradyarrhythmia, Heart failure, Hypertension, Hypotension Gastrointestinal: Nausea (less than 5%), Taste sense altered (8%-42%), Vomiting (less than 5%), Xerostomia (less than 5%) Neurologic: Dizziness (less than 5%), Headache (less than 5%) Ophthalmic: Blepharitis (5%), Blurred vision (5% to 15%), Burning sensation in eye (12%-30%), Conjunctival hyperemia (5% to 15%), Excessive tear production (15%), Itching of eye (5% to 15%), Light intolerance (5% to 15%), Pain in eye (1%-14%) Psychiatric: Depression (less than 5%) Respiratory: Bronchitis, Dyspnea, Nasal congestion (less than 5%), Upper respiratory infection (less than 5%) |
| Pregnancy          | Human Data Suggest Risk in 2nd and 3rd Trimesters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| More Info          | [UpToDate](https://www.uptodate.com/contents/dorzolamide-and-timolol-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

